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Background: We studied the effects of single nucleotide polymorphisms (SNPs) in the metabotropic glutamate
receptor 3 (GRM3) gene on brain N-acetylaspartate (NAA) concentrations and executive function (EF) skills in
non-smoking, active alcoholics, and evaluated associations between these variables.
Methods: SNPs (rs6465084, rs1468412, and rs2299225) in GRM3 were genotyped in 49 male, non-smoking,
alcohol-dependent patients and 45 healthy control subjects using ligase detection reactions. NAA/creatine (Cr)
ratios in left prefrontal gray matter (GM) and white matter (WM), left parietal GM, left parietal WM, and cerebellar
vermis regions were measured by Proton 1 H Magnetic resonance spectroscopy (MRS). EF was measured by the
Wisconsin Card Sorting Test (WCST).
Results: Compared to controls, alcoholics had lower NAA/Cr ratios in prefrontal GM and WM regions and
performed more poorly on all EF tests (P< 0.001). Alcoholics with the A/A genotype for SNP rs6465084 had
lower NAA/Cr ratios in prefrontal GM and WM regions and had poorer EF skills than alcoholics who were
G-carriers for this SNP (P< 0.01). Non-alcoholics with the A/A genotype for rs6465084 also had lower NAA/Cr
levels in prefrontal GM and made more random errors in the WCST than G-carriers (P< 0.01). The A/A genotype
group for SNP rs6465084 was significantly different from the G carriers for the variables of NAA/Cr ratios and
WCST scores in both alcoholics and controls (P< 0.05). Alcoholics who were T-carriers for rs1468412 had lower
NAA/Cr ratios in prefrontal GM and showed poorer EF skills (P< 0.05). No effects of rs2299225 genotype on
NAA/Cr or executive skills were observed. NAA/Cr in left prefrontal regions correlated with certain parameters
of EF testing in both alcoholics and controls (P< 0.05), but the significance of this correlation among alcoholics
disappeared after adjustment for the effects of genotype.
Conclusions: Our results provide evidence that glutamate system dysfunction may play a role in the prefrontal
functional abnormalities seen in alcohol dependence. It is possible that certain GRM3 SNP genotypes (the A/A
genotype of rs6465084 and the T allele of rs1468412) may further lower NAA/Cr levels and EF skills in addition
to the effect of alcohol.
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Alcohol dependence and abuse are among the most
costly health problems in the world from both social
and economic points of view, resulting from interplay
among polygenic, sociocultural, and environmental fac-
tors. The long-term effects of chronic alcohol abuse on
brain damage and cognition have been well documented
[1-3]. Genetic factors may play a role in the vulnerabil-
ity to and severity of alcohol-induced brain damage
[4,5].
Alcohol dependence is partly due to dysregulation of
glutamate transmission in the brain [6,7]. Glutamate is
the major excitatory neurotransmitter in the central
nervous system and mediates its actions via activation
of both ionotropic and metabotropic receptor families.
Metabotropic glutamate receptors (mGlus) have
received much attention in the neuropsychiatric com-
munity over the past decade, and have become targets
of drug developers searching for medicines to treat
schizophrenia, depression, anxiety, drug addiction, and
dementia [8,9]. mGlus are divided into three groups,
mGluI-mGluIII, based on signal transduction pathways
and sequence homology [10]. The metabotropic glu-
tamate receptor 3 (GRM3), a member of the group II
family of mGlus, is coupled to second message path-
ways via GTP-binding proteins and is involved in pre-
synaptic depression by decreasing the evoked release of
glutamate [11].
The GRM3 gene has been mapped to 7q21.1–q21.2,
spanning 220.1 kb [12], and is a candidate gene for sus-
ceptibility to schizophrenia. The single nucleotide poly-
morphism (SNP) rs6465084 in intron 2 has been
associated with reduced prefrontal cortical levels of
N-acetylaspartate/ Creatine (NAA/Cr) and verbal fluency
in schizophrenic and healthy subjects [13,14]. Two SNPs,
rs1468412 and rs2299225 in intron 3, were reported to
be associated with schizophrenia in Japanese and Chinese
populations, respectively [11,15].
Several animal studies have looked at the influence
of GRM3 activation on alcohol dependence and addic-
tion to other drugs [16-21]. In one study, the mGlu2/3
receptor agonist LY379268 attenuated alcohol self-
administration and cue-induced reinstatement [16].
Another study demonstrated that the same GRM2/3
agonist (LY379268) was effective at reducing ethanol
self-administration and stress-induced reinstatement
following dependence-inducing ethanol exposure [21].
Furthermore, GRM3 mRNA levels were found to be
down-regulated in rat strains genetically selected for al-
cohol self-administration preference [19]. These results
suggest that GRM2/3 receptors may be good targets
for treatment of for alcohol addiction.
Magnetic resonance spectroscopy (MRS) is the neuroi-
maging method of choice for noninvasive monitoring ofin vivo brain chemistry, and provides a unique oppor-
tunity to gain insight into the biochemical pathology of
neurological and psychiatric disorders. MRS enables
measurement of aspects of alcohol-induced brain dam-
age that may accompany or precede alcohol-induced
morphological changes [22-26]. The brain metabolite
concentrations measured by MRS include N-
acetylaspartate (NAA), choline-containing compounds
(Cho), creatine and phosphocreatine (Cr), myo-inositol
(mI), and lactate. NAA is an amino acid derivative that
is found in high concentrations in axons and dendrites
of neurons, particularly in pyramidal neurons [27], and
NAA levels are thought to reflect neuronal viability [28].
Decreased NAA levels usually suggest neuronal loss or
atrophied dendrites and/or axons [29]. Cr is involved in
the bioenergetics of neuronal and glial tissue. Levels of
this metabolite generally do not vary with pathological
status, making it useful as an internal reference to other
brain metabolites [30-34]. Because smoking has been
shown to influence NAA/Cr levels regardless of alcohol
consumption [23-25,35], we ascertained study partici-
pants who were non-smokers to avoid any additional ef-
fect of smoking on this investigation. Several studies
have suggested that chronic cigarette smoking adversely
affects both brain neurobiology and neurocognition in
alcohol use disorders. MRS studies comparing smoking
and non-smoking recovering alcoholics found lower
NAA concentrations in the frontal [23-25] and medial
temporal lobes [35] of the smokers. Examining alco-
holics as a homogeneous group, without consideration
of smoking status, may obscure the real effect of alcohol
on neurocognitive injuries.
We hypothesized that chronic alcohol consumption
would lead to a measurable reduction in MRS-
measured NAA/Cr levels and poor performance on ex-
ecutive function (EF) tests. Furthermore, we speculated
that in addition to the direct effect of alcohol, certain
SNPs (rs6465084, rs1468412, and rs2299225) in the
GRM3 gene may contribute to lower NAA/Cr levels in
one or more brain regions and to lower EF skills
through modulation of synaptic glutamate. The goal of
this study was to investigate the effects of GRM3 SNP
genotypes on brain NAA concentrations and EF skills in




Forty-nine male, non-smoking, heavy drinkers were
recruited from the Mental Health Centre of 1st Hospital
of Harbin Medical University, China. All patients met
the DSM-IV criteria for alcohol dependence and con-
sumed more than 70 g of pure ethanol daily for at least
3 years without smoking and were not abstaining from
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control subjects were recruited from the same hospital.
Alcohol consumption by the control subjects, if any, was
consistent with that of a mild social drinker, with a mean
of 4 g of pure ethanol per day and a maximum of 12 g
per day (one subject). Control subjects were carefully
screened for any past or present alcohol- or drug-related
problems. All subjects were Han Chinese in origin be-
tween the ages of 18 and 60 y at the time of enrollment.
Participants were excluded from the study for any con-
comitant psychiatric disorder, antisocial personality dis-
order, organic liver failure, and medical or neurological
illness or trauma that would affect the central nervous
system. This study was approved by the local Ethics
Committee, and all subjects provided written informed
consent. All subjects, particularly the alcohol-dependent
group, were operating at their full cognitive capacities at
the time they gave their informed consent.
Alcohol consumption questionnaires were collected
from each study participant. Data collected included age
of onset of alcohol dependence, duration of alcohol de-
pendence, estimated daily alcohol intake, estimated
number of drinks in the prior month, estimated drinks
per day and per month in the past year, and lifetime esti-
mated alcohol intake. Pure alcohol intake was computed
in drink/day (one drink was defined as 12 oz of beer,
5 oz of wine, or 1.5 oz of liquor, corresponding to ap-
proximately 13.6 g of pure alcohol).
Genotyping
The three SNPs studied in the GRM3 gene, rs6465084
(A/G), rs1468412(A/T), and rs2299225(G/T) (http://
www.ncbi.nlm.nih.gov/SNP/), reside within introns. Gen-
omic DNA was isolated from whole blood using the
AxyPrep-96 genomic DNA kit (Axygen Biotechnology
Company, China) according to the manufacturer's instruc-
tions. Genotyping was done using ligase detection reac-
tions (LDR). All three target DNA sequences were
amplified in a multiplex PCR reaction. The PCR reaction
was carried out in a final volume of 20 μl containing 1X
PCR buffer, 3 mM Mg2+, 2 mM dNTP, 1U/μl Taq DNA
ligase (Qiagen Company, Germany), 1X Q-solution, 5 pM
primer [see Additional file 1], 1 pmol of each common
probe [see Additional file 2], and 1 μl genomic DNA. The
reaction conditions were 95°C for 15 m, 35 cycles of 94°C
for 30 s, 56°C for 90 s, and 72°C for 1 m, followed by a
final extension at 72°C for 7 m. The ligation reaction was
carried out in a final volume of 10 μl containing 1X buf-
fer, 1 μl Probe Mix, 0.05 μl ligase, 1 μl Multi-PCR
product, and 1 pmol of each discriminating oligo. The
LDR reaction conditions were 95°C for 2 m, and
30 cycles of 94°C for 30 s and 50°C for 2 m. The fluor-
escent products of LDR were differentiated using the
ABI sequencer 500.Magnetic resonance spectroscopic imaging acquisition
and processing
Proton magnetic resonance spectroscopic imaging
(MRSI) was performed with a 3.0 T Philips Vision sys-
tem (Philips Company, Netherlands), as described by
Meyerhoff et al. [22]. MRI was followed by automated
head shimming and a multislice 1 H MRSI sequence
with TR, TI, and TE of 1800, 165, and 25 ms, respect-
ively, 15° flip angle, circular k-space sampling, and three
15 mm thick slices, with a slice gap of at least 6 mm,
angulated parallel to the double spin-echo slices. The
first MRSI plane was positioned through the cerebellum
and pons using two anatomical landmarks for reprodu-
cible slice positioning on the sagittal view. The junction
of the pons and midbrain and the corner of the fourth
ventricle and vermis were used to determine the angula-
tion and position of the oblique transverse slice through
the cerebellum and pons. The second slice was posi-
tioned superior to the lateral ventricles including frontal
lobe gray and white matter and the anterior cingulate
gyrus. Regions of interest (RoIs, 20 mm×20 mm×
20 mm) were drawn on the left prefrontal gray matter
(GM), left prefrontal white matter (WM), left parietal
GM, left parietal WM, and the cerebellar vermis (five
brain regions most susceptible to alcohol consumption)
with an atlas-based method (Figure 1). The total acquisi-
tion time was approximately 45 minutes for both MRI
and MRSI.
Metabolite signals of NAA and Cr were calculated
from the MRSI data using an automated spectral fitting
program (Philips Company, the Netherlands). Metabolite
signal intensities were reported as the area under the
peaks and used to calculate NAA/Cr ratio. Cr values
were used as a reference because the total amount of Cr
appears to be constant under different metabolic condi-
tions [31]. Moreover, total Cr resonance is generally not
expected to be affected by alcohol [32-34]. A representa-
tive spectrum and its fit after subtraction of the fitted
baseline are depicted in Figure 2.
Neurocognitive assessment
Wisconsin Card Sorting Test (WCST) was administered
within 1 day of the magnetic resonance study. The test
(~20 min in duration) is a commonly used instrument
to measure frontal EF such as concept formation, set-
shifting, and flexibility. Using a computerized 48-card
version of the WCST, the subjects were required to
match response cards to 4 stimulus cards along 1 of 3
dimensions (color, form, or number) on the basis of ver-
bal feedback (correct or incorrect). The participants
were not given any information about the dimensions.
After a certain number of correct answers, the sorting
rule was changed without warning. The output para-
meters of the WCST included number of correct
Figure 1 Regions of interest (RoIs). RoIs in this study were the left prefrontal GM (A), left prefrontal WM (B), left parietal GM (C), left parietal
WM (D), and cerebellar vermis (E).
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egories completed.
Statistical analyses
The effects of GRM3 genotype on cognitive abilities
and NAA/Cr ratio measures were assessed using the
combination of unpaired t tests and multivariate ana-
lysis of variance (MANOVA). Many genotypes were
examined in this data set, but Bonferroni correction forall combinations seems overly stringent [13]. The results
of unpaired t tests were corrected for multiple tests
using MANOVA. Potential confounding factors (demo-
graphic and clinical variables) were also examined but
were not significant. The variables were all normally dis-
tributed, thus the samples were evaluated using Pearson
correlation coefficients to assess the association between
NAA/Cr levels and changes in EF skills, with or without
the adjustment of variables by genotypes.
Figure 2 Representative spectrum showing NAA and Cr measurements. Peak integral values were determined by a fit curve algorithm at
2.0 ppm for NAA and 3.0 ppm for Cr.
Table 2 Genotype frequencies of three SNPs in the GRM3
gene in alcoholics and controls
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Participant characteristics
Demographics and estimated alcohol consumption in
alcoholic and control group are shown in Table 1.
Genotype frequencies for the three SNPs in GRM3 are
shown in Table 2. The age, education, and genotype
frequencies were not significantly different between
alcoholics and controls. Subjects in different genotype
groups did not differ significantly by age, education, or
alcohol consumption.
Brain metabolite levels and neurocognition test results
for alcohol-dependent and control subjects
The combination of unpaired t tests and MANOVA
were used in this analysis. NAA/Cr ratio measurementsTable 1 Demographics and estimated alcohol





Age 46.0 ± 6.5 46.3 ± 5.8
Education (years) 11.7 ± 3.5 11.9 ± 3.0
Onset age of alcohol dependence 28.5 ± 5.2 NA
Duration of alcohol dependence (years) 17.3 ± 6.2 NA
Estimated average drinks a per day in
prior month
11 ± 5 0.4 ± 0.2
Estimated drinks in prior month 324± 143 11 ± 7
Estimated drinks per day last year 11 ± 5 0.4 ± 0.2
Estimated drinks per month last year 358± 153 11 ±7
Estimated lifetime alcohol drinks 85430± 57290 3432± 1399
NA: Not applicable.
a One drink is equivalent to 12 oz beer, 5 oz wine, or 1.5 oz liquor containing
approximately 13.6 g of ethanol.in each RoI and WCST scores for alcoholics and con-
trols are given in Table 3. The alcohol-dependent group
differed from the controls (F= 17.18, v1 = 9, v2 = 82,
P < 0.001) for the variables which included all NAA/Cr
levels and WCST scores in the MANOVA. The alcohol-
dependent group was also different from the controls
(F= 8.12,v1 = 5, v2 = 86, P < 0.001) only for the variables
of NAA/Cr levels. The alcohol-dependent group (n= 49)
had lower NAA/Cr levels in left prefrontal GM
(t=−2.59, df= 92, P= 0.011) and in the prefrontal WM
(t=−6.03, df= 80, P < 0.001) compared to the controls
(n= 45) using unpaired t tests. The NAA/Cr ratios in theSNP Genotype, number and frequency
Alcoholic group
rs6465084 A/A A/G G/G
31 (63.3%) 17 (34.7%) 1 (2.0%)
rs1468412 A/A A/T T/T
30 (61.2%) 17 (34.7%) 2 (4.1%)
rs2299225 T/T G/T G/G
37 (75.5%) 12 (24.5%) 0
Control group
rs6465084 A/A A/G G/G
29 (64.4%) 16 (35.6%) 0
rs1468412 A/A A/T T/T
27 (60.0%) 17 (37.8%) 1 (2.2%)
rs2299225 T/T G/T G/G
30 (66.7%) 15 (33.3%) 0









Left Prefrontal GM 1.59 ± 0.13 1.66 ± 0.12 −2.59 92 0.011a
Left Prefrontal WM 1.58 ± 0.12 1.70 ± 0.07 −6.03 80 <0.001b
Left Parietal GM 1.53 ± 0.09 1.55 ± 0.07 −1.24 91 0.220
Left Parietal WM 1.56 ± 0.10 1.56 ± 0.06 −0.33 77 0.746
Cerebellar vermis 0.94 ± 0.06 0.94 ± 0.06 −0.07 90 0.946
F= 8.12,v1 = 5,v2 = 86,P< 0.001c
Number of corrects 30.37 ± 3.73 37.78 ± 2.37 −11.58 82 <0.001b
Perseverative errors 11.49 ± 3.39 6.04 ± 2.44 8.87 92 <0.001b
Random errors 6.18 ± 2.64 4.18 ± 1.34 4.70 72 <0.001b
Categories completed 2.08 ± 1.59 4.93 ± 0.65 −11.52 65 <0.001b
F= 37.74,v1 = 4,v2 = 89,P< 0.001d
F= 17.18,v1 = 9,v2 = 82,P< 0.001e
a Value is statistically significant (P< 0.05).
b Value is statistically significant (P< 0.001).
c Alcoholic group was different from controls for the variables of NAA/Cr levels.
d Alcoholic group was different from controls for the variables of WCST scores.
e Alcoholic group was different from controls for the variables including all the
NAA/Cr levels and WCST scores.
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the groups. The alcohol-dependent group differed from
the controls (F= 37.74, v1 = 4, v2 = 89, P < 0.001) for the
variables of WCST scores in the MANOVA. The
alcohol-dependent group performed more poorly than
control subjects in the number of correct responses
(t=−11.58, df=82, P< 0.001), perseverative errors (t=8.87,Figure 3 SNP rs6465084 genotypes and NAA/Cr ratios. NAA/Cr ratio le
rs6465084 genotype. Statistically significant differences (P < 0.05) due to gedf=92, P< 0.001), random errors (t=4.70, df=72,
P<0.001), and categories completed (t=−11.52, df=65,
P<0.001, unpaired t tests).
GRM3 SNP genotypes and NAA/Cr ratios
Because of unequal variances of certain genotypes for
SNP rs6465084, we combined the individuals with the
A/G heterozygous genotype and those with the G/G
homozygous genotype into a G carrier group for analysis
as described previously [13,14]. We performed a similar
grouping for analysis of SNP rs1468412, in which the
A/T heterozygotes and T/T homozygotes were combined
into a T carrier group.
Among alcoholics, those having the A/A genotype for
SNP rs6465084 were significantly different from the G
carriers for the variables of NAA/Cr levels in the MAN-
OVA (F= 5.26, v1 = 5, v2 = 41, P < 0.001). The A/A geno-
type group had statistically significantly lower NAA/Cr
levels in the left prefrontal GM (t=−3.20, df= 41,
P= 0.003) and in the prefrontal WM (t=−3.76, df= 47,
P < 0.001) compared to the G carriers in unpaired t tests
(Figure 3). No other NAA/Cr ratios in the other brain
RoIs were significantly different between carriers of dif-
ferent rs6465084 SNP genotypes (Figure 3). For SNP
rs1468412, alcoholics in the T carrier group weren’t dif-
ferent from those with the A/A genotype for the vari-
ables of NAA/Cr levels in the MANOVA (F= 1.65,
v1 = 5, v2 = 41, P= 0.168). But we found that the T carrier
group had lower NAA/Cr levels in the left prefrontal
GM (t=−2.89, df= 47, P= 0.006) compared to those with
the A/A genotype in unpaired t tests (Figure 4). Novels in different brain regions of alcoholics and controls by SNP
notype are marked (*).
Figure 4 SNP rs1468412 genotypes and NAA/Cr ratios. NAA/Cr ratio levels in different brain regions of alcoholics and controls by SNP
rs1468412 genotype. Statistically significant differences (P < 0.05) due to genotype are marked (*).
Xia et al. Behavioral and Brain Functions 2012, 8:42 Page 7 of 11
http://www.behavioralandbrainfunctions.com/content/8/1/42other NAA/Cr ratios in other brain RoIs were signifi-
cantly different between carriers of different rs1468412
SNP genotypes. For SNP rs2299225, there were no sig-
nificant differences in NAA/Cr levels in any brain RoIs
between the T/T and G/T genotype groups in either the
MANOVA or the unpaired t tests.
We performed the same analysis on the non-alcoholic
control subjects and found that the group having the A/A
genotype for SNP rs6465084 was significantly different
from the G carriers for the variables of NAA/Cr levels in
the MANOVA (F= 11.11,v1 = 5, v2 = 39, P < 0.001). The
A/A genotype group for SNP rs6465084 had statistically
significantly lower NAA/Cr levels in the left prefrontal
GM (t=−7.42, df= 43, P < 0.001) compared to the G
carrier group in unpaired t tests (Figure 3). No other
NAA/Cr ratios in the other brain RoIs were signifi-
cantly different between carriers of different rs6465084
SNP genotypes (Figure 3). For SNPs rs1468412 and
rs2299225, there were no significant differences in
NAA/Cr levels in any brain RoIs between different
genotype groups in either the MANOVA or the un-
paired t tests.
For all subjects, the A/A genotype group for SNP
rs6465084 was significantly different from G carriers for
the variables of NAA/Cr levels in the MANOVA
(F= 9.11, v1 = 5, v2 = 86, P < 0.001). There were no sig-
nificant differences between genotype groups for the
variables of NAA/Cr levels for SNPs rs1468412 and
rs2299225.GRM3 SNP genotypes and neurocognition
Among alcoholics, those having the A/A genotype for
SNP rs6465084 differed significantly from the G carriers
for the variables of WCST scores in the MANOVA
(F= 31.35, v1 = 4, v2 = 44, P < 0.001). The A/A genotype
of SNP rs6465084 was a predictor of poorer perform-
ance on EF skills tests in the areas of number of correct
responses (t=−6.17, df= 47, P < 0.001), perseverative
errors (t= 4.21, df= 47, P < 0.001), random errors
(t= 2.88, df= 47, P= 0.006), and categories completed
(t=−9.83, df= 47, P < 0.001) compared to G carriers
(Table 4). For SNP rs1468412, alcoholics in the T carrier
group did not differ from those with the A/A genotype
for the variables of WCST scores in the MANOVA
(F= 1.61, v1 = 4, v2 = 44, P= 0.188). Unpaired t tests indi-
cated that the T carriers for SNP rs1468412 scored sig-
nificantly lower in the number of correct responses
(t=−2.20, df= 47, P= 0.033) and categories completed
(t=−2.43, df= 47, P =0.019) than carrier of the A/A
genotype (Table 4). There were no significant differences
in WCST performance scores between the T/T and G/T
genotype groups in an analysis of SNP rs2299225 using
both MANOVA and unpaired t tests (Table 4).
Among non-alcoholic controls, the A/A genotype
group for SNP rs6465084 was significantly different
from the G carriers for WCST scores in the MANOVA
(F= 3.28, v1 = 3, v2 = 41, P= 0.030). Those having the
A/A genotype of SNP rs6465084 made statistically
significantly more random errors (t= 2.79, df= 43,
Table 4 Scores achieved on the Wisconsin Card Sorting Test (WCST) by GRM3 SNP genotype
WCST parameters rs6465084 rs1468412 rs2299225
A/A group G carrier group T carrier group A/A group T/T group G/T group
Alcoholic group (n= 31) (n= 18) (n= 19) (n= 30) (n= 37) (n= 12)
Number of corrects 28.48 ± 3.16 a 33.61 ± 2.03 28.95 ± 3.58 b 31.27 ± 3.60 30.05 ± 4.05 31.33 ± 2.42
Perseverative errors 12.68 ± 3.54 a 9.44 ± 1.82 12.53 ± 3.91 10.83 ± 2.90 11.59 ± 3.57 11.17 ± 2.89
Random errors 6.87 ± 2.87 a 5.00 ± 1.68 6.58 ± 3.06 5.93 ± 2.36 6.41 ± 2.87 5.50 ± 1.68
Categories completed 1.10 ± 0.98 a 3.78 ± 0.81 1.42 ± 1.35 b 2.50 ± 1.61 2.00 ± 1.51 2.33 ± 1.87
F= 31.35, v1 = 4, v2 = 44, P< 0.001 c F= 1.61, v1 = 4, v2 = 44, P =0.188 F= 0.47, v1 = 4, v2 = 44, P= 0.757
Control group (n= 29) (n= 16) (n= 18) (n= 27) (n=30) (n= 15)
Number of corrects 37.72 ± 2.46 37.88 ± 2.28 37.67 ± 2.43 37.85 ± 2.38 37.67 ± 2. 50 38.00 ± 2.17
Preservative errors 5.25 ± 1.88 6.48 ± 2.63 6.17 ± 2. 43 5.96 ± 2.49 6.30 ± 2.56 5.53 ± 2.17
Random errors 4.88 ± 1.20 a 3.79 ± 1.26 4.17 ± 1.34 4.19 ± 1.36 4.03 ± 1.19 4.47 ± 1.60
Categories completed 5.00 ± 0.60 4.81 ± 0.75 4.78 ± 0.73 5.04 ± 0.59 4.93 ± 0.64 4.93 ± 0.70
F= 3.28, v1 = 3, v2 = 41, P= 0.030 d F= 0.72, v1 = 3, v2 = 41, P =0.543 F=0.51, v1 = 3, v2 = 41, P= 0.676
F= 3.43,v1 = 4,v2 = 89,P= 0.012 e F= 0.73,v1 = 4,v2 = 89,P= 0.574 F=0.58,v1 = 4,v2 = 89,P= 0.681
a Value is statistically significantly different (P< 0.01) than that found in the comparison group for that SNP.
b Value is statistically significantly lower (P< 0.05) than that found in the comparison group for that SNP.
c The A/A genotype group for SNP rs6465084 was significantly different from the G carriers for the variables of WCST scores among alcoholics.
d The A/A genotype group for SNP rs6465084 was significantly different from the G carriers for the variables of WCST scores among controls.
e The A/A genotype group for SNP rs6465084 was significantly different from the G carriers for the variables of WCST scores in all the subjects.
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were no other significant differences in WCST scores
among the varying SNP genotypes among control sub-
jects either in the MANOVA or in unpaired t tests
(Table 4).
For all the subjects, the A/A genotype group for SNP
rs6465084 was significantly different from the G carriers
for the variables of WCST scores in the MANOVA
(F= 3.43,v1 = 4,v2 = 89,P= 0.012). There were no signifi-
cant differences between genotype groups for the vari-
ables of WCST scores for SNPs rs1468412 and
rs2299225.
The relationship between NAA/Cr levels and
neurocognition
Among alcoholics, higher NAA/Cr levels in the pre-
frontal WM region were associated with a greater num-
ber of correct responses (r= 0.379, P= 0.007) and
categories completed (r= 0.433, P= 0.002). Among con-
trols, higher NAA/Cr levels in the prefrontal WM region
were associated with a greater number of correct
responses (r= 0.358, P= 0.015) and fewer perseverative
errors (r=−0.431, P= 0.003). There were no other statis-
tically significant relationships between NAA/Cr levels
in other brain regions or in neurocognition.
After adjustment for the effect of genotypes, there were
no significant relationships between NAA/Cr levels and
neurocognition in the alcoholic subjects group. Among
controls, higher NAA/Cr levels in the prefrontal WM re-
gion were associated with a greater number of correct
responses (r=0.365, P=0.017) and fewer perseverativeerrors (r=−0.427, P=0.004), excluding the influence of
genotype.
Discussion
In the present study, we assessed brain metabolite
(NAA/Cr) levels and neurocognition performance in 49
non-smoking, active alcoholics and 45 non-smoking
control subjects and analyzed the findings with respect
to genotype at three GRM3 SNPs. The alcohol-
dependent subjects in this study had lower NAA/Cr
levels in left prefrontal GM and WM regions compared
to controls and performed more poorly on EF skills tests
than controls. Reduction of NAA levels in frontal WM
has been demonstrated previously in active heavy drin-
kers [22]. Other studies in alcoholics abstinent for 3–
40 days have shown lower NAA levels in the frontal
lobes [36], thalamus [37], and cerebellum [33], suggest-
ing neuronal injury, atrophied dendrites and/or axons,
and/or mitochondrial dysfunction. Although the changes
in brain NAA concentrations measured in these studies
are small, the prefrontal and temporal regions appeared
to be especially impacted by alcohol abuse. Meyerhoff
et al. [22] demonstrated higher absolute concentrations
of Cr in parietal GM of active heavy drinkers. Although
we did not measure these, elevated absolute Cr levels
might account for the lower NAA/Cr ratios observed in
alcoholics in this study. The measurement of NAA/Cr
ratios rather than absolute metabolite concentrations of
NAA and Cr is a recognized limitation of this study. It
has been shown that alcohol abuse is associated with a
clear and consistent pattern of general cognitive deficits,
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[38]. The results of our study also suggest that brain
damage in prefrontal regions and poor performance of
EF tests were directly related to ethanol consumption.
We did not measure blood alcohol levels of the partici-
pants at the time of MRS and cognitive testing since the
influence of residual blood alcohol level on NAA and Cr
levels is likely to be small [22]; however we do acknow-
ledge that they could potentially affect cognitive test
performance.
The effect of GRM3 SNPs on alcoholism has not
been reported to our knowledge, therefore there are
not specific studies regarding this. Our rationale for
studying GRM3 in alcoholism is based on this SNP's
involvement in other neuro-psychiatric diseases. The
GRM3 SNPs in this study (rs6465084, rs1468412, and
rs2299225) are the same as those reported to be asso-
ciated with schizophrenia [11,13,15]. We observed a re-
lationship between the A/A genotype of GRM3 SNP
rs6465084 and lower NAA/Cr ratios in prefrontal GM
and WM regions of alcoholics and in prefrontal GM of
controls. These findings are consistent with prior stud-
ies in which this genotype was associated with lower
NAA/Cr levels in the dorsolateral prefrontal cortex of
healthy volunteers [14] and in which the A allele was
associated with lower NAA/Cr levels in the prefrontal
cortex of schizophrenia patients [13]. We observed a
similar relationship between the T allele of SNP
rs1468412 and reduced NAA/Cr levels in the prefrontal
GM of alcoholics in this study. This finding has not
been confirmed by others. The A/A genotype group
for SNP rs6465084 was significantly different from the
G carriers for all the variables of NAA/Cr levels in
both alcoholics and controls, also indicating the obvi-
ous effect of A/A genotype for SNP rs6465084 on
NAA/Cr levels. The glutamate signaling system has
long been implicated in the acute and chronic effects
of alcohol [6,7]. Based on evidence that GRM3 modu-
lates synaptic glutamate, that it is a receptor for
N-acetyl-aspartyl-glutamate, and that NAA is related to
mitochondrial activity and to glutamate levels, the
prefrontal reduction of NAA/Cr levels may reflect a
genetically influenced alteration in glutamate neuro-
transmission [14].
While overall neurocognitive abilities were lower in
alcoholics compared to controls, we also observed an ef-
fect of certain GRM3 SNP genotypes on cognitive abil-
ities. In alcoholics, the A/A genotype of rs6465084 and
the T allele of rs1468412 were associated with poorer EF.
Among controls, the A/A genotype of SNP rs6465084
was associated with a single measured parameter of EF.
Our findings agree with those of others, who have also
suggested a relationship between SNP genotypes and
individual variability in brain metabolite levels andinefficient prefrontal cortical functioning [39], and the
evidence presented here of pattern of neurobiological
and neurocognitive abnormalities [26,40,41]. Given that
the A allele of SNP rs6465084 has been related to
suboptimal glutamatergic signaling with an association
between the A/A genotype of SNP rs6465084 and
decreased prefrontal NAA/Cr levels and with poorer
cognitive functioning in alcohol-dependent subjects,
we believe that GRM3 gene variants may play a role
in alcoholism.
In this study, we found that NAA/Cr levels in the pre-
frontal regions were associated with performance of EF
in both alcoholic and control subjects. This is similar to
previous findings in which lower NAA concentrations in
the frontal lobe were associated with poorer perfor-
mances on measures of EF skills and working memory
in active-drinking and short-term abstinent alcoholics
[22,26,33,36]. Lower test scores on WCST suggest
poorer neurocognitive skills and functional brain damage
in alcoholics, perhaps related to decreased NAA levels.
Because we observed an obvious correlation between
certain GRM3 SNP genotypes and NAA/Cr ratios and
cognitive abilities, the relationship between NAA/Cr
levels and neurocognition was also studied after the ad-
justment for the effect of genotype. The significant rela-
tionship between NAA/Cr levels and neurocognition
among alcoholics disappeared after adjustment for geno-
type. Therefore the exact relationship between SNP gen-
otypes, brain metabolite levels, and neurocognition is
unclear, since these findings were not confirmed in the
control group.Conclusions
We found that (1) non-smoking, active alcoholics with-
out abstinence had lower NAA/Cr levels in prefrontal
regions and performed more poorly on EF skills tests
compared to control subjects; (2) certain GRM3 SNP
genotypes were associated with lower levels of the glu-
tamate metabolite NAA and with poorer performance
on EF tests in alcoholics; and (3) NAA/Cr levels in pre-
frontal regions were associated with EF skills in both
alcoholic and control subjects, but the significant rela-
tionship between NAA/Cr level and neurocognition
among alcoholics disappeared after adjustment for the
effect of genotype. Our results provide evidence that
glutamate system dysfunction may play a role in the
prefrontal functional abnormalities seen in alcohol de-
pendence. It is possible that certain GRM3 SNP geno-
types (i.e., the A/A genotype of rs6465084 and the T
allele of rs1468412) may further lower NAA/Cr levels
and EF skills in addition to the effect of alcohol. We
hope to perform these studies on a larger population
to verify these relationships.
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